$67.63
+2.42%Price chart
Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9Sep 14
ValuationView details →
P/E (Fwd)
17.8x
EV/EBITDA
18.1x
Market Cap
$32.69B
MomentumView details →
1D Return
+2.42%
YTD Return
−14.26%
RSI (14)
37.6
ValuationView details →
P/E (Fwd)
17.8x
EV/EBITDA
18.1x
Market Cap
$32.69B
RSI (14)
37.6
MomentumView details →
1D Return
+2.42%
YTD Return
−14.26%
SummaryUpdated Jun 1, 2026
Alcon Inc. (NYSE:ALC) is a Swiss-headquartered eye care company that was spun off from Novartis and went public in 2019. Founded in 1945, Alcon has grown to become one of the world's largest dedicated eye care companies, focusing exclusively on developing, manufacturing, and distributing products for eye care professionals and their patients globally. The company operates through two primary business segments: Surgical and Vision Care, serving ophthalmologists, optometrists, and consumers worldwide with a comprehensive portfolio of eye care solutions.
Similar companies
Latest newsMore news →